infections during HVP. "The procedure is potentially associated with delayed alkalosis due to high citrate load ( FFP) in the case of liver failure" Tree of the 16 children developed pH>7,55 within the first 12 hours after HVP and were treated with HCL. CONCLUSIONS: In a small group of children no major adverse events of plasmapheresis were seen, and no procedure related mortality. Mortality was high especially among the youngest children. This patient group was highly selected with poor prognosis even prior to enrollment and we might have past the opportunity to treat due to the progression of P-ALF before initiation of HVP. ) were compared in standard bicarbonate hemodialysis: PEPA (low pore size) (5 pts), Helixone (18 pts), Polyphenylene (7 pts). Reduction rates (RR) of urea, phosphorus, creatinine, ß2-microglobulin, myoglobin, and RBP were measured during one hemodialysis session. Plasma concentrations of PIC (IL-6, TNF-alpha and IL-1ß) were measured before and after the session. The loss of albumin in the effluent dialysate was measured with the Polyphenylene membrane. RESULTS: Kt/V and RR of small molecules are identical according to the type of membrane. RR of ß2-microglobulin are comparable whereas myoglobin RR for PEPA and Polyphenylene membranes are higher than those for Helixone (0.5060.14, 0.5960.13 vs 0.2460.06, p <0.0001). RR of RBP for Polyphenylene membrane is higher than Helixone (0.3760.15 vs 0.0960.25, p ¼ 0.013). Plasma concentrations of CKI do not vary significantly between the beginning and the end of the session. The loss of albumin in dialysate for Polyphenylene, the most efficient membrane, is 1.9761 g / session.There are significant differences between membranes for the heaviest MM removal (myoglobin MW ¼ 17184 Da and RBP MW ¼ 21200 Da). The values are identical to those observed in hemodiafiltration. The most efficient membrane does not cause albumin loss beyond the recommended thresholds (5g/session). No significant increase in PIC concentration was observed. CONCLUSIONS: Standard hemodialysis with HF Polyphenylene membrane allows middle molecules removal close to performance levels obtained in hemodialfiltration, without PIC production and without risk of protein malnutrition by albumin loss. Pharmalogy, University Hospital of Saint Etienne, Saint Etienne, France and 4 Nephrology, Dialysis, Transplantation, University Hospital Saint Etienne, Saint-Priest en Jarez, France INTRODUCTION AND AIMS: Sustained low-efficiency dialysis (SLED) has become a frequent renal replacement therapy (RRT) technique used in intensive care unit (ICU) patients but little is known about the effect of SLED on antibiotics clearance. Many studies have reported data regarding clearance of vancomycin during continuous and/or intermittent RRT. However, only few data are available regarding SLED. Here, we realised a meta-analysis of RRT vancomycin clearance during continuous and intermittent RRT. METHODS: We conducted a systematic review of published article on pharmacokinetic of vancomycin during RRT. The literature search was conducted from the PubMed database up to august 2017. A model based meta-analysis [1] of RRT vancomycin clearance in function of RRT settings (blood, dialysate and hemofiltration flow rate) was performed using a non-linear mixed effect model. To guide the choice of dosing regimen, we used previously published population pharmacokinetic data [2,3] to simulate the pharmacokinetic of vancomycin in ICU patient undergoing SLED. Vancomycin clearance was splited in two parts: i) the residual body clearance [3] and ii) the clearance due to SLED obtain from the model constructed by meta-analysis. RESULTS: A total of 28 articles were included in the study corresponding to 69 RRT clearance measurements. The model described adequately the measurements with no apparent bias between observed and predicted clearances. Based on population pharmacokinetic simulations, with a 2g daily vancomycin bolus, time spend below the therapeutic target of 15 mg/l was estimated to 25.2 h [17.6-50.9] (median, Q1-Q3) for
INTRODUCTION AND AIMS:
Middle Molecules (MM) removal, inflammation and nutritional status are determining factors in the prognosis of chronic hemodialysis patients. High-Flux dialyzers (HF) allow in standard hemodialysis an efficient removal of MM by causing albumin loss which may limit their use. Their effect on the production and elimination of pro-inflammatory cytokines (PIC) has not been studied. METHODS: 30 patients were included in an observational study. 3 types of HF membranes with the same surface area (2m 2 ) were compared in standard bicarbonate hemodialysis: PEPA (low pore size) (5 pts), Helixone (18 pts), Polyphenylene (7 pts). Reduction rates (RR) of urea, phosphorus, creatinine, ß2-microglobulin, myoglobin, and RBP were measured during one hemodialysis session. Plasma concentrations of PIC (IL-6, TNF-alpha and IL-1ß) were measured before and after the session. The loss of albumin in the effluent dialysate was measured with the Polyphenylene membrane. RESULTS: Kt/V and RR of small molecules are identical according to the type of membrane. RR of ß2-microglobulin are comparable whereas myoglobin RR for PEPA and Polyphenylene membranes are higher than those for Helixone (0.5060.14, 0.5960 
Sustained low-efficiency dialysis (SLED) has become a frequent renal replacement therapy (RRT) technique used in intensive care unit (ICU) patients but little is known about the effect of SLED on antibiotics clearance. Many studies have reported data regarding clearance of vancomycin during continuous and/or intermittent RRT. However, only few data are available regarding SLED. Here, we realised a meta-analysis of RRT vancomycin clearance during continuous and intermittent RRT. METHODS: We conducted a systematic review of published article on pharmacokinetic of vancomycin during RRT. The literature search was conducted from the PubMed database up to august 2017. A model based meta-analysis [1] of RRT vancomycin clearance in function of RRT settings (blood, dialysate and hemofiltration flow rate) was performed using a non-linear mixed effect model. To guide the choice of dosing regimen, we used previously published population pharmacokinetic data [2, 3] to simulate the pharmacokinetic of vancomycin in ICU patient undergoing SLED. Vancomycin clearance was splited in two parts: i) the residual body clearance [3] and ii) the clearance due to SLED obtain from the model constructed by meta-analysis. RESULTS: A total of 28 articles were included in the study corresponding to 69 RRT clearance measurements. The model described adequately the measurements with no apparent bias between observed and predicted clearances. Based on population pharmacokinetic simulations, with a 2g daily vancomycin bolus, time spend below the therapeutic target of 15 mg/l was estimated to 25.2 h [17.6-50.9] (median, Q1-Q3) for patient undergoing SLED 8h per day for 5 days. If a 2g vancomycin bolus is administrated at the end of the first SLED session, time spend below the therapeutic target is then estimated to 0. Nephrology, Army Force Hospital, Cairo, Egypt INTRODUCTION AND AIMS: Although procalcitonin (PCT) has been described as a new marker of infection and inflammation, it has not been extensively studied in hemodialysis patients.Aim of the work: we studied the acute effect of hemodialysis session among patients with ESRD on the serum procalcitonin level in low versus high flux hemodialysis and the effect of Hemodialysis modality on its clearance values METHODS: We measured PCT serum levels and high sensitivity C-Reactive protein (hs-CRP) before and immediately after hemodialysis in 50 adult hemodialysis patients (25 treated with high-flux Allmed Polypure Sþ polysulphone membrane, steam sterilized, with a surface area of 1.6 m2 for at least 6 months, and 25 with low-flux Allmed Polypure S polysulphone membrane, steam sterilized, with a surface area of 1.6 m2 for at least 6 months), all patients were without history of concurrent infections during the clinical study RESULTS: The baseline PCT levels before HD were higher than healthy individuals. There was a highly significant decrease in PCT serum levels after HD session in patients undergoing hemodialysis by high-flux membranes but not by low-flux membranes (high-flux 0.54ng|ml pre-HD Vs 0.26 ng/ml post-HD, p¼0.001; while in low-flux 0.50ng|ml Vs 0.53 ng/ml, p¼0.066) Hs-CRP levels were unchanged in both groups .There was no correlation between PCT and CRP. we also found that the pre dialysis s.Phosphorus was significantly lower in High Flux Group versus the Low Flux Group ( 4.4 mg/dl versus 5.6 mg/dl respectively p ¼0.004 we also did not find significant correlation between predialysis s.PCT level with either Age , BMI , dialysis vintage , URR or Kt/V for both low and high flux groups CONCLUSIONS: Although PCT is considered a sensitive and specific diagnostic and prognostic marker of systemic bacterial infection, we suggest that specific reference ranges might be developed in patients with impaired renal function and also its clinical usefulness might be changed in interpretation between different patients according to the membrane fluxes used in hemodialysis sessions 
